DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

ScanX - Stock Screener & Market Research Platform Built for India

scanx.trade 9 hrs ago·7 Oct 2026, 7:14 pm

ScanX has launched a new stock screener and market research platform designed specifically for the Indian investor. This tool aims to simplify the process of finding investment opportunities by allowing users to filter stocks based on specific financial criteria and market data.

For retail investors, this development is significant as it provides a dedicated resource to navigate the complexities of the market. By offering a user-friendly interface, ScanX helps investors make more informed decisions by providing easy access to essential research tools.

Investors should monitor how this platform is adopted by the retail community. The success of ScanX will depend on its ability to provide accurate data and a seamless user experience, which could set a new standard for market research tools in India.